Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDS
NCT ID: NCT07025096
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
350 participants
INTERVENTIONAL
2025-12-05
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this randomized, survey-based study is to compare treatment recommendations enacted by clinicians to those generated by an AI CDSS. The study will investigate whether an AI CDSS can generate treatment recommendations that are safe, appropriate, and indistinguishable to those provided by real clinicians.
In this study, participants (i.e., critical care clinicians) will review a series of critical care cases (vignettes) in an electronic survey. Each vignette will contain a de-identified case of a patient with sepsis and ARDS as well as treatment recommendations for the case. Participants will assess the safety and appropriateness of each treatment recommendations and answer whether they think the treatment recommendations came from the clinician or an AI CDSS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence for Sepsis Prediction in ICU
NCT04913181
Artificial Intelligence Prognostic Model for Sepsis Based on Time Series Analysis
NCT06724120
Impact and Safety of AI in Decision Making in the ICU: a Simulation Experiment
NCT05495438
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
NCT06272942
The Early Prediction of Sepsis in ICU
NCT05088850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Artificial Intelligence
Critical care cases / vignettes in this arm will contain treatment recommendations generated by an artificial intelligence-based clinical decision support system. Each participant will review four vignettes from this arm.
Artifical Intelligence-Generated Treatment Recommendations
The clinical vignette will contain treatment recommendations which were generated by an artificial intelligence-based clinical decision support system.
Human Clinician
Critical care cases / vignettes in this arm will contain treatment recommendations that were enacted by the clinician in the actual case. Each participant will review four vignettes from this arm.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artifical Intelligence-Generated Treatment Recommendations
The clinical vignette will contain treatment recommendations which were generated by an artificial intelligence-based clinical decision support system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Working at a hospital or medical center in medical critical care, anesthesia critical care, surgical critical care, or emergency medicine
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of General Medical Sciences (NIGMS)
NIH
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Weissman, MD, MSHP
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
858201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.